Strong improvement in State-Trait Anger Expression Inventory 2 (STAXI-2) Trait Anger, a measure of agitation and aggression, at Weeks 8–12 compared to previous top line data; nominal statistical ...

Agitation-Aggression in Borderline Personality Disorder (BPD) acknowledged as a possible therapeutic indication Oryzon may use STAXI-2 Trait anger as a primary efficacy endpoint for PORTICO-2 ...

Borderline personality disorder (BPD) is a severe and complex personality disorder associated with instability in interpersonal relations, behavior, and emotions. Emotional dysregulation is a key ...

Thirty years ago when I first started training as a psychiatrist and providing inpatient care to adolescents and young adults with borderline personality disorder (BPD), there was a tremendous amount ...

Oryzon Genomics will seek the FDA’s advice after a psychiatric drug failed to impact the symptoms or severity of borderline personality disorder, but executives are keen to push forward with refreshed ...

Leading US psychiatric experts join Oryzon’s Clinical Advisory Board (CAB) to advance Phase III development of vafidemstat in Borderline Personality Disorder (BPD) CAB and Oryzon establish primary and ...

MADRID and CAMBRIDGE, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, ...

The Brain & Behavior Research Foundation (BBRF) will host a free webinar, “Evaluating the Potential of a Sleep Intervention Among Youth at High-Risk for Borderline Personality Disorder” on Tuesday, ...

Borderline personality disorder (BPD) is a type of personality disorder characterized by instability. BPD typically emerges during adolescence or early adulthood. While BPD diagnosis usually occurs ...